Oncotelic Therapeutics Inc Sustainability Reports
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for treating cancer and rare pediatric diseases. The company leverages multiple platform technologies, including AI-enhanced infrastructure and nanotechnology-enabled drug delivery systems, to optimize and advance oncology treatments.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001S7F0V0
1 reports from 2024 to 2024
